Docetaxel- and 5-FU-concurrent radiotherapy in patients presenting unresectable locally advanced pancreatic cancer: a FNCLCC-ACCORD/0201 randomized phase II trial's pre-planned analysis and case report of a 5.5-year disease-free survival
Titel:
Docetaxel- and 5-FU-concurrent radiotherapy in patients presenting unresectable locally advanced pancreatic cancer: a FNCLCC-ACCORD/0201 randomized phase II trial's pre-planned analysis and case report of a 5.5-year disease-free survival
Auteur:
Oberic, Lucie Viret, Frédéric Baey, Charlotte Ychou, Marc Bennouna, Jaafar Adenis, Antoine Peiffert, Didier Mornex, Françoise Pignon, Jean-Pierre Celier, Patrice Berille, Jocelyne Ducreux, Michel